Insider Cluster

CRVS insider trading

Corvus Pharmaceuticals, Inc.

In the past 68 days, 1 insider bought $50K of Corvus Pharmaceuticals, Inc. stock in 1 open-market purchase. The largest purchase was $50K by Jeffrey Arcara (Chief Business Officer) on Nov 11, 2026.

Insider purchases

InsiderValueHoldingsSignalTraded / filed
Jeffrey Arcara
Chief Business Officer
$50K
4,500 sh @ $11.22
New position Medium
  • Opens a new position
Nov 11, 2026
Filed Nov 13, 2026

Insider sales

No open-market sales by insiders in this period.

Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.

Unsubscribe any time. No spam, no stock picks.